{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:42:40Z","timestamp":1790430160026,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.jns.2006.05.064","type":"journal-article","created":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T10:01:21Z","timestamp":1152612081000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["MSA-C is the predominant clinical phenotype of MSA in Japan: Analysis of 142 patients with probable MSA"],"prefix":"10.1016","volume":"249","author":[{"given":"Ichiro","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2006.05.064_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2006.05.064_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"\u03b1-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2006.05.064_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","article-title":"What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?","volume":"68","author":"Wenning","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib4","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2006.05.064_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","article-title":"Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy","volume":"32","author":"Graham","year":"1969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib6","first-page":"262","article-title":"Multiple system atrophy","volume":"vol. 3","author":"Quinn","year":"1994"},{"key":"10.1016\/j.jns.2006.05.064_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000078506","article-title":"Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France","volume":"23","author":"Chrysostome","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2006.05.064_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.parkreldis.2004.04.008","article-title":"Comparison of magnetic resonance imaging in subtypes of multiple system atrophy","volume":"10","author":"Lee","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","article-title":"What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study","volume":"54","author":"Litvan","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.05.064_bib10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.WNL.0000028690.15001.00","article-title":"Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?","volume":"59","author":"Osaki","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"Wenning","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy: a meta-analysis","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy: an analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.jns.2006.05.064_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","article-title":"Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT","volume":"57","author":"Schulz","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2006.05.064_bib18","first-page":"330","article-title":"L'atrophie olivo-ponto-cerebelleuse","volume":"13","author":"Dejerine","year":"1900","journal-title":"Nouv. iconogr. Salp\u00e9tri\u00e8re"},{"key":"10.1016\/j.jns.2006.05.064_bib19","first-page":"37","article-title":"A clinicopathological study on extrapyramidal components in cerebellar degeneration with special reference to olivo-ponto-cerebellar atrophy","volume":"21","author":"Hirayama","year":"1997","journal-title":"Shinkei Kenkyu No Shimpo"},{"key":"10.1016\/j.jns.2006.05.064_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2004.08.013","article-title":"Fragile X gene premutation in multiple system atrophy","volume":"227","author":"Garland","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2006.05.064_bib21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.55.12.1918","article-title":"Multiple system atrophy\/progressive supranuclear palsy: alpha-synuclein, synphilin, tau, and APOE","volume":"55","author":"Morris","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/mds.20491","article-title":"Brain-derived neurotrophic factor gene polymorphism in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy","volume":"20","author":"Nishimura","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00415-004-0546-5","article-title":"No association between FMR1 premutations and multiple system atrophy","volume":"251","author":"Yabe","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2006.05.064_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/mds.10540","article-title":"Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy","volume":"18","author":"Combarros","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molbrainres.2005.04.011","article-title":"Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA)","volume":"138","author":"Furiya","year":"2005","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.jns.2006.05.064_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2004.09.023","article-title":"Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy","volume":"228","author":"Infante","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2006.05.064_bib27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/mds.10124","article-title":"Contribution of the interleukin-1 beta gene polymorphism in multiple system atrophy","volume":"17","author":"Nishimura","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2004.10.056","article-title":"Kawakami H. Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy","volume":"374","author":"Nishimura","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2006.05.064_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2005.09.003","article-title":"Heredity in multiple system atrophy","volume":"240","author":"Soma","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2006.05.064_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.2003.025155","article-title":"Probable multiple system atrophy in a German family","volume":"75","author":"Wullner","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","article-title":"ESGAP Consortium. Case-control study of multiple system atrophy","volume":"20","author":"Vanacore","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.05.064_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archneur.56.1.90","article-title":"Multiple system atrophy: the putative causative role of environmental toxins","volume":"56","author":"Hanna","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.05.064_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01826052","article-title":"Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation","volume":"1","author":"Nee","year":"1991","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jns.2006.05.064_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.55.4.527","article-title":"An H. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy","volume":"55","author":"Gilman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.2003.029595","article-title":"Cognitive bedside assessment in atypical parkinsonian syndromes","volume":"7","author":"Bak","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.05.064_bib36","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib38","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.57.6.1140","article-title":"Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA","volume":"57","author":"Orimo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.064_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clineuro.2004.12.005","article-title":"Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease","volume":"107","author":"Mito","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jns.2006.05.064_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00702-005-0351-z","article-title":"Functional imaging with positron emission tomography in multiple system atrophy","volume":"112","author":"Gilman","year":"2005","journal-title":"J Neural Transm"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06002826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06002826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:37:40Z","timestamp":1758382660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06002826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0022510X06002826"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2006.05.064","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MSA-C is the predominant clinical phenotype of MSA in Japan: Analysis of 142 patients with probable MSA","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2006.05.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}